country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Further studies on the specificity of proglumide as a selective cholecystokinin antagonist in the central nervous system

Ann N Y Acad Sci. 1985;448:345-51. doi: 10.1111/j.1749-6632.1985.tb29929.x.

B S Bunney , L A Chiodo , A S Freeman

PMID: 2862828 DOI: 10.1111/j.1749-6632.1985.tb29929.x

Products

Cat. No.

Product Name

Description

Target

Research Area
HY-B1330

Proglumide

99.84%, CCK-A/B Receptors Antagonist

target: Cholecystokinin Receptor

Research Areas: Neurological Disease; Endocrinology; Cancer
HY-103354

Proglumide sodium

99.58%, CCK-A/B Receptors Antagonist

target: Cholecystokinin Receptor

Research Areas: Neurological Disease; Endocrinology; Cancer
HY-103354A

Proglumide hemicalcium

CCK-A/B Receptors Antagonist

target: Cholecystokinin Receptor

Research Areas: Neurological Disease; Endocrinology; Cancer
HY-103354R

Proglumide sodium (Standard)

CCK-A/B Receptors Antagonist

target: Reference Standards; Cholecystokinin Receptor

Research Areas: Neurological Disease; Endocrinology; Cancer
HY-B1330R

Proglumide (Standard)

CCK-A/B Receptors Antagonist

target: Cholecystokinin Receptor; Reference Standards

Research Areas: Neurological Disease; Endocrinology; Cancer